Infectious Disease Morbidity Among Young HIV-1-Exposed But Uninfected Infants in Latin American and Caribbean Countries: The National Institute of Child Health and Human Development International Site Development Initiative Perinatal Study

• Published in: Pediatrics (Evanston) 2007-03, Vol.119 (3), p.e694-e704
• Main Authors: Mussi-Pinhata, Marisa M, Freimanis, Laura, Yamamoto, Aparecida Y, Korelitz, James, Pinto, Jorge A, Cruz, Maria L. S, Losso, Marcelo H, Read, Jennifer S, National Institute of Child Health and Human Development International Site Development Initiative Perinatal Study Group
• Format: Article
• Language: English
• Subjects: Anemia - epidemiology; Anti-Bacterial Agents - therapeutic use; Anti-Retroviral Agents - therapeutic use; Babies; Caribbean Region - epidemiology; Cohort Studies; Communicable Diseases - epidemiology; Communicable Diseases - immunology; Comorbidity; Confidence Intervals; Female; Follow-Up Studies; HIV; HIV Infections - epidemiology; HIV Infections - immunology; HIV Seronegativity; HIV-1 - immunology; Hospitalization - statistics & numerical data; Human immunodeficiency virus; Human immunodeficiency virus 1; Humans; Infant; Infant mortality; Infant, Newborn; Infectious diseases; Latin America - epidemiology; Male; Multivariate Analysis; Odds Ratio; Pediatrics; Pregnancy; Pregnancy Complications, Infectious - drug therapy; Pregnancy Complications, Infectious - epidemiology; Prenatal Exposure Delayed Effects - epidemiology; Prenatal Exposure Delayed Effects - immunology; Prospective Studies; Socioeconomic Factors
• ISSN: 0031-4005; 1098-4275
• DOI: 10.1542/peds.2006-1856

The goal was to describe the frequency, characteristics, and correlates of infectious disease morbidity during the first 6 months of life among HIV-1-exposed but uninfected infants. The study population consisted of infants enrolled in the National Institute of Child Health and Human Development International Site Development Initiative Perinatal Study who were HIV-1 uninfected and had follow-up data through the 6-month study visit. Definitive and presumed infections were recorded at study visits (birth, 6-12 weeks, and 6 months). Of 462 HIV-1-uninfected infants with 11,644 child-weeks of observation, 283 experienced > or = 1 infection. These 283 infants experienced 522 infections (1.8 infections per infant). The overall incidence rate of infections was 4.5 cases per 100 child-weeks of observation. Overall, the most common infections were skin or mucous membrane infections (1.9 cases per 100 child-weeks) and respiratory tract infections (1.7 cases per 100 child-weeks). Thirty-six percent of infants had > 1 respiratory tract infection (1.8 cases per 100 child-weeks). Incidence rates of upper and lower respiratory tract infections were similar (0.89 cases per 100 child-weeks and 0.9 cases per 100 child-weeks, respectively). Cutaneous and/or oral candidiasis occurred in 48 neonates (10.3%) and 92 older infants (19.3%). Early neonatal sepsis was diagnosed in 12 infants (26.0 cases per 1000 infants). Overall, 81 of 462 (17.5%) infants were hospitalized with an infection. Infants with lower respiratory tract infections were hospitalized frequently (40.7%). The occurrence of > or = 1 neonatal infection was associated with more-advanced maternal HIV-1 disease, tobacco use during pregnancy, infant anemia, and crowding. Lower maternal CD4+ cell counts, receipt of intrapartum antibiotic treatment, and country of residence were associated with postneonatal infections. Close monitoring of HIV-1-exposed infants, especially those who are anemic at birth or whose mothers have more-advanced HIV-1 disease or who smoked during pregnancy, remains important.